EA200000310A1 - April - новый белок, воздействующий на рост - Google Patents

April - новый белок, воздействующий на рост

Info

Publication number
EA200000310A1
EA200000310A1 EA200000310A EA200000310A EA200000310A1 EA 200000310 A1 EA200000310 A1 EA 200000310A1 EA 200000310 A EA200000310 A EA 200000310A EA 200000310 A EA200000310 A EA 200000310A EA 200000310 A1 EA200000310 A1 EA 200000310A1
Authority
EA
Eurasian Patent Office
Prior art keywords
april
growth
new protein
protein impact
impact
Prior art date
Application number
EA200000310A
Other languages
English (en)
Other versions
EA005411B1 (ru
Inventor
Юрг Чопп
Original Assignee
Апотек Р Энд Д Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Апотек Р Энд Д Са filed Critical Апотек Р Энд Д Са
Publication of EA200000310A1 publication Critical patent/EA200000310A1/ru
Publication of EA005411B1 publication Critical patent/EA005411B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/525Tumour necrosis factor [TNF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

APRIL, новый член семейства факторов некроза опухолей (TNF), модифицированные формы APRIL и содержащие их фармацевтические композиции.Отчет о международном поиске был опубликован 1999.06.03.
EA200000310A 1997-09-12 1998-09-11 Применение антитела против полипептида april для получения лекарственного препарата для лечения опухолей EA005411B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5878697P 1997-09-12 1997-09-12
US7938498P 1998-03-26 1998-03-26
PCT/US1998/019191 WO1999012965A2 (en) 1997-09-12 1998-09-11 April- a novel protein with growth effects

Publications (2)

Publication Number Publication Date
EA200000310A1 true EA200000310A1 (ru) 2000-10-30
EA005411B1 EA005411B1 (ru) 2005-02-24

Family

ID=26738027

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000310A EA005411B1 (ru) 1997-09-12 1998-09-11 Применение антитела против полипептида april для получения лекарственного препарата для лечения опухолей

Country Status (20)

Country Link
US (3) US20030138884A1 (ru)
EP (1) EP1027431A2 (ru)
JP (1) JP2001515712A (ru)
KR (1) KR100618492B1 (ru)
CN (1) CN1195849C (ru)
AU (1) AU759717B2 (ru)
BR (1) BR9812634A (ru)
CA (1) CA2303615A1 (ru)
CZ (1) CZ294615B6 (ru)
EA (1) EA005411B1 (ru)
EE (1) EE200000147A (ru)
HU (1) HUP0004611A3 (ru)
IL (1) IL134537A0 (ru)
IS (1) IS5378A (ru)
NO (1) NO20001242L (ru)
NZ (1) NZ503850A (ru)
PL (1) PL339463A1 (ru)
SK (1) SK3542000A3 (ru)
TR (1) TR200000669T2 (ru)
WO (1) WO1999012965A2 (ru)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
AU1700999A (en) * 1997-11-26 1999-06-15 Eli Lilly And Company Tnf ligand family gene
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
US20030095967A1 (en) 1999-01-25 2003-05-22 Mackay Fabienne BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
EP1415659B9 (en) 1999-01-25 2012-02-15 Biogen Idec MA Inc. An antibody specific for soluble BAFF for use in the treatment of cancer
US20030022233A1 (en) 1999-04-30 2003-01-30 Raymond G. Goodwin Methods of use of the taci/taci-l interaction
KR20090016772A (ko) 1999-08-17 2009-02-17 바이오겐 아이덱 엠에이 인코포레이티드 Baff 수용체(bcma), 면역조절제
WO2001025256A2 (en) * 1999-10-06 2001-04-12 University Of Utah Research Foundation Trdl-1-gamma, a novel tumor necrosis-like ligand
UA74798C2 (ru) * 1999-10-06 2006-02-15 Байоджен Айдек Ма Інк. Способ лечения рака у млекопитающих с помощью полипептида, который препятствует взаимодействию между april и его рецепторами
CA2897626C (en) 2000-02-11 2020-03-24 Biogen Idec Ma Inc. Heterologous polypeptide of the tnf family
AU2006201471B2 (en) * 2000-02-16 2009-07-23 Genentech, Inc. Uses of agonists and antagonists to modulate activity of TNF-related molecules
DE60028830T2 (de) * 2000-02-16 2007-01-18 Genentech, Inc., South San Francisco Anti-april antikörper und hybridomazellen
EP1280826B1 (en) * 2000-05-12 2007-05-02 Amgen Inc. Polypeptides for inhibiting april-mediated b- and t-cell proliferation.
EP2431054A3 (en) * 2000-06-15 2013-03-06 Human Genome Sciences, Inc. Human tumor necrosis factor delta and epsilon
UA83458C2 (ru) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Выделенный полипептид baff-r (рецептор фактора активации в-клеток семейства tnf)
GB2370273A (en) * 2000-12-20 2002-06-26 Viaxxel Biotech Gmbh Compounds that affect CD83 expression
JP2004537290A (ja) 2001-05-24 2004-12-16 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 腫瘍壊死因子δ(APRIL)に対する抗体
EA007275B1 (ru) 2001-05-24 2006-08-25 Займодженетикс, Инк. Слитые белки taci-иммуноглобулина
CA2472049A1 (en) 2002-01-04 2003-07-17 Xencor Dominant negative proteins and methods thereof
US7381792B2 (en) 2002-01-04 2008-06-03 Xencor, Inc. Variants of RANKL protein
WO2004089982A2 (en) * 2003-01-06 2004-10-21 Xencor April variants and methods thereof
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
JP5524441B2 (ja) 2003-03-28 2014-06-18 バイオジェン・アイデック・エムエイ・インコーポレイテッド 短縮されたbaffレセプター
CA2554526A1 (en) * 2004-01-29 2005-08-18 Genentech, Inc. Variants of the extracellular domain of bcma and uses thereof
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
WO2005113598A2 (en) * 2004-05-21 2005-12-01 Xencor, Inc. Tnf super family members with altered immunogenicity
CA2590461A1 (en) 2004-12-23 2006-06-29 Laboratoires Serono S.A. Bcma polypeptides and uses thereof
KR20080056714A (ko) 2005-08-09 2008-06-23 지모제넥틱스, 인코포레이티드 TACI―Ig 융합 분자를 사용하여 B―세포 악성종양을치료하는 방법
WO2007019573A2 (en) 2005-08-09 2007-02-15 Zymogenetics, Inc. Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules
EP1934258B1 (en) * 2005-09-26 2011-03-02 Enzo Life Sciences (ELS) AG Antibodies against april as biomarkers for early prognosis of lymphoma patients
US20070086979A1 (en) 2005-10-13 2007-04-19 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
US9726673B2 (en) 2005-11-23 2017-08-08 Genentech, Inc. Methods and compositions related to B cell assays
BRPI0711823A2 (pt) 2006-05-15 2012-01-17 Ares Trading Sa métodos para tratamento de doenças auto-imunes com uma molécula de fusão taci-ig
ES2928709T3 (es) 2009-03-02 2022-11-22 Aduro Biotech Holdings Europe B V Anticuerpos frente a un ligando inductor de proliferación (APRIL)
WO2011109280A1 (en) 2010-03-05 2011-09-09 Lerner Research Institute Methods and compositions to treat immune-mediated disorders
EP2542679A1 (en) * 2010-03-05 2013-01-09 Academisch Medisch Centrum bij de Universiteit van Amsterdam B-cell stimulating fusion proteins of an antigen with baff or april
NL2011406C2 (en) * 2013-09-06 2015-03-10 Bionovion Holding B V Method for obtaining april-binding peptides, process for producing the peptides, april-binding peptides obtainable with said method/process and use of the april-binding peptides.
SI3175706T1 (sl) * 2013-09-23 2019-03-29 Regeneron Pharmaceuticals, Inc. Nehumane živali s humaniziranim genom signal-regulatornega proteina
GB201317929D0 (en) * 2013-10-10 2013-11-27 Ucl Business Plc Chimeric antigen receptor
AU2014353347B2 (en) * 2013-11-19 2020-07-02 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
NL2014108B1 (en) 2015-01-09 2016-09-30 Aduro Biotech Holdings Europe B V Altered april binding antibodies.
EP4285923A3 (en) 2015-11-25 2024-03-06 Visterra, Inc. Antibody molecules to april and uses thereof
US11484027B2 (en) 2020-10-29 2022-11-01 Industrial Polymers and Chemicals, Inc. Air filter with pathogen monitoring and inactivation
WO2023019223A2 (en) 2021-08-11 2023-02-16 Akso Biopharmaceutical Inc. METHODS OF REDUCING PRODUCTION OF IgA, IgM AND/OR IgG USING sBCMA VARIANTS AND FC FUSION PROTEINS THEREOF

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176996A (en) * 1988-12-20 1993-01-05 Baylor College Of Medicine Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
US5256775A (en) * 1989-06-05 1993-10-26 Gilead Sciences, Inc. Exonuclease-resistant oligonucleotides
US5264564A (en) * 1989-10-24 1993-11-23 Gilead Sciences Oligonucleotide analogs with novel linkages
AU6166396A (en) * 1995-06-07 1996-12-30 Biogen, Inc. Complexes of modified lymphotoxins as pharmaceutical prepara tions
ATE254135T1 (de) * 1996-03-14 2003-11-15 Human Genome Sciences Inc Humaner tumornekrosefaktor delta und epsilon
US6509170B1 (en) * 1996-03-14 2003-01-21 Human Genome Sciences, Inc. Polynucleotides encoding human tumor necrosis factor delta
US6171787B1 (en) * 1997-06-26 2001-01-09 Abbott Laboratories Member of the TNF family useful for treatment and diagnosis of disease

Also Published As

Publication number Publication date
NO20001242D0 (no) 2000-03-09
PL339463A1 (en) 2000-12-18
SK3542000A3 (en) 2000-08-14
US20050112596A1 (en) 2005-05-26
WO1999012965A2 (en) 1999-03-18
EP1027431A2 (en) 2000-08-16
JP2001515712A (ja) 2001-09-25
WO1999012965A3 (en) 1999-06-03
HUP0004611A2 (hu) 2001-04-28
IL134537A0 (en) 2001-04-30
CA2303615A1 (en) 1999-03-18
US20060084148A1 (en) 2006-04-20
NZ503850A (en) 2002-12-20
CZ2000869A3 (cs) 2000-09-13
CN1270632A (zh) 2000-10-18
EE200000147A (et) 2001-02-15
IS5378A (is) 2000-02-18
HUP0004611A3 (en) 2002-04-29
AU9316298A (en) 1999-03-29
TR200000669T2 (tr) 2000-08-21
EA005411B1 (ru) 2005-02-24
CZ294615B6 (cs) 2005-02-16
NO20001242L (no) 2000-05-11
AU759717B2 (en) 2003-04-17
KR100618492B1 (ko) 2006-08-31
BR9812634A (pt) 2000-08-22
CN1195849C (zh) 2005-04-06
US20030138884A1 (en) 2003-07-24
KR20010023893A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
EA200000310A1 (ru) April - новый белок, воздействующий на рост
EA200000311A1 (ru) Новый белок иммунной системы - кау
EA199900187A1 (ru) Лиганд, родственный фактору некроза опухоли
EA199900643A1 (ru) Сульфамидные ингибиторы металлопротеаз
EA200300073A1 (ru) Фармацевтические композиции ингибиторов белка переноса холестериловых эфиров
DE68911195T2 (de) Wenig klebende Zusammensetzungen von Perfluoropolyether.
EA199900381A1 (ru) Арил(тио)эфиры галогенпиримидина в качестве пестицидов
DK0650512T3 (da) Aldehyd-hærdet klæbemiddel på grundlag af protein
EA199901013A1 (ru) Гели пролонгированного действия
EA200000196A1 (ru) Универсальная плазма крови
DE3883743D1 (de) Aminosäuren, nützlich bei Leberstörungen.
MX9302927A (es) Nuevos peptidos, la preparacion y utilizacion de los mimos.
EA199901113A1 (ru) Карбоксамиды в качестве агонистов 5-ht1f
EA199800753A1 (ru) Бензотиофены, составы их содержащие и способы с их использованием
EA199900534A1 (ru) Имидазопиридазины
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
AU2511901A (en) Basolateral sorting signal and inhibitors thereof
ATE385805T1 (de) Neue peptide
SE9602822D0 (sv) New receptor
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
NZ330464A (en) Methods for the preparation of biphenyl isoxazole sulfonamides
EA200000112A1 (ru) Новая композиция
EA200001127A1 (ru) Бактериальные феромоны и их использование
AU5163598A (en) Novel hepatitis b inhibitors
ZA931191B (en) IBV spike protein (2).